|
1
|
Gurtu V and Michelakis ED: Emerging
therapies and future directions in pulmonary arterial hypertension.
Can J Cardiol. 31:489–501. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Tuder RM: Pathology of pulmonary arterial
hypertension. Semin Respir Crit Care Med. 30:376–385. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Michelakis ED, Webster L and Mackey JR:
Dichloroacetate (DCA) as a potential metabolic-targeting therapy
for cancer. Br J Cancer. 99:989–994. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Paulin R and Michelakis ED: The metabolic
theory of pulmonary arterial hypertension. Circ Res. 115:148–164.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Schermuly RT, Dony E, Ghofrani HA,
Pullamsetti S, Savai R, Roth M, Sydykov A, Lai YJ, Weissmann N,
Seeger W, et al: Reversal of experimental pulmonary hypertension by
PDGF inhibition. J Clin Invest. 115:2811–2821. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Berghausen E, ten Freyhaus H and
Rosenkranz S: Targeting of platelet-derived growth factor signaling
in pulmonary arterial hypertension. Handb Exp Pharmacol.
218:381–408. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Xiao Y, Peng H, Hong C, Chen Z, Deng X,
Wang A, Yang F, Yang L, Chen C and Qin X: PDGF promotes the warburg
effect in pulmonary arterial smooth muscle cells via activation of
the PI3K/AKT/mTOR/HIF-1α signaling pathway. Cell Physiol Biochem.
42:1603–1613. 2017. View Article : Google Scholar
|
|
8
|
Rehman J and Archer SL: A proposed
mitochondrial-metabolic mechanism for initiation and maintenance of
pulmonary arterial hypertension in fawn-hooded rats: The Warburg
model of pulmonary arterial hypertension. Adv Exp Med Biol.
661:171–185. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
McMurtry MS, Bonnet S, Wu X, Dyck JR,
Haromy A, Hashimoto K and Michelakis ED: Dichloroacetate prevents
and reverses pulmonary hypertension by inducing pulmonary artery
smooth muscle cell apoptosis. Circ Res. 95:830–840. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Guignabert C, Tu L, Izikki M, Dewachter L,
Zadigue P, Humbert M, Adnot S, Fadel E and Eddahibi S:
Dichloroacetate treatment partially regresses established pulmonary
hypertension in mice with SM22alpha-targeted overexpression of the
serotonin transporter. FASEB J. 23:4135–4147. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Michelakis ED, McMurtry MS, Wu XC, Dyck
JR, Moudgil R, Hopkins TA, Lopaschuk GD, Puttagunta L, Waite R and
Archer SL: Dichloroacetate, a metabolic modulator, prevents and
reverses chronic hypoxic pulmonary hypertension in rats: Role of
increased expression and activity of voltage-gated potassium
channels. Circulation. 105:244–250. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lambert CM, Roy M, Robitaille GA, Richard
DE and Bonnet S: HIF-1 inhibition decreases systemic vascular
remodelling diseases by promoting apoptosis through a hexokinase
2-dependent mechanism. Cardiovasc Res. 88:196–204. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Semenza GL: Hypoxia-inducible factor 1:
Oxygen homeostasis and disease pathophysiology. Trends Mol Med.
7:345–350. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wilson JE: Isozymes of mammalian
hexokinase. Structure, subcellular localization and metabolic
function. J Exp Biol. 206:2049–2057. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Pastorino JG and Hoek JB: Hexokinase II:
The integration of energy metabolism and control of apoptosis. Curr
Med Chem. 10:1535–1551. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yasuda S, Arii S, Mori A, Isobe N, Yang W,
Oe H, Fujimoto A, Yonenaga Y, Sakashita H and Imamura M: Hexokinase
II and VEGF expression in liver tumors: Correlation with
hypoxia-inducible factor 1 alpha and its significance. J Hepatol.
40:117–123. 2004. View Article : Google Scholar
|
|
17
|
Riddle SR, Ahmad A, Ahmad S, Deeb SS,
Malkki M, Schneider BK, Allen CB and White CW: Hypoxia induces
hexokinase II gene expression in human lung cell line A549. Am J
Physiol Lung Cell Mol Physiol. 278:L407–L416. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Yan J, Shen Y, Wang Y and Li BB: Increased
expression of hypoxia-inducible factor-1α in proliferating
neointimal lesions in a rat model of pulmonary arterial
hypertension. Am J Med Sci. 345:121–128. 2013. View Article : Google Scholar
|
|
19
|
Zhuo B, Li Y, Li Z, Qin H, Sun Q, Zhang F,
Shen Y, Shi Y and Wang R: PI3K/Akt signaling mediated Hexokinase-2
expression inhibits cell apoptosis and promotes tumor growth in
pediatric osteosarcoma. Biochem Biophys Res Commun. 464:401–406.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bonnet S, Paulin R, Sutendra G, Dromparis
P, Roy M, Watson KO, Nagendran J, Haromy A, Dyck JR and Michelakis
ED: Dehydroepiandrosterone reverses systemic vascular remodeling
through the inhibition of the Akt/GSK3-{beta}/NFAT axis.
Circulation. 120:1231–1240. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Dromparis P, Sutendra G and Michelakis ED:
The role of mitochondria in pulmonary vascular remodeling. J Mol
Med. 88:1003–1010. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Assad TR and Hemnes AR: Metabolic
dysfunction in pulmonary arterial hypertension. Curr Hypertens Rep.
17:202015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Haugrud AB, Zhuang Y, Coppock JD and
Miskimins WK: Dichloroacetate enhances apoptotic cell death via
oxidative damage and attenuates lactate production in
metformin-treated breast cancer cells. Breast Cancer Res Treat.
147:539–550. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Allen KT, Chin-Sinex H, DeLuca T,
Pomerening JR, Sherer J, Watkins JB III, Foley J, Jesseph JM and
Mendonca MS: Dichloroacetate alters Warburg metabolism, inhibits
cell growth, and increases the X-ray sensitivity of human A549 and
H1299 NSC lung cancer cells. Free Radic Biol Med. 89:263–273. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Antoniu SA: Targeting PDGF pathway in
pulmonary arterial hypertension. Expert Opin Ther Targets.
16:1055–1063. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Peng H, Xiao Y, Deng X, Luo J, Hong C and
Qin X: The Warburg effect: A new story in pulmonary arterial
hypertension. Clin Chim Acta. 461:53–58. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Bonnet S, Michelakis ED, Porter CJ,
Andrade-Navarro MA, Thébaud B, Bonnet S, Haromy A, Harry G, Moudgil
R, McMurtry MS, et al: An abnormal mitochondrial-hypoxia inducible
factor-1alpha-Kv channel pathway disrupts oxygen sensing and
triggers pulmonary arterial hypertension in fawn hooded rats:
Similarities to human pulmonary arterial hypertension. Circulation.
113:2630–2641. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wong JY, Huggins GS, Debidda M, Munshi NC
and De Vivo I: Dichloroacetate induces apoptosis in endometrial
cancer cells. Gynecol Oncol. 109:394–402. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Madhok BM, Yeluri S, Perry SL, Hughes TA
and Jayne DG: Dichloroacetate induces apoptosis and cell-cycle
arrest in colorectal cancer cells. Br J Cancer. 102:1746–17521.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Sun RC, Board PG and Blackburn AC:
Targeting metabolism with arsenic trioxide and dichloroacetate in
breast cancer cells. Mol Cancer. 10:1422011. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Stacpoole PW, Nagaraja NV and Hutson AD:
Efficacy of dichloroacetate as a lactate-lowering drug. J Clin
Pharmacol. 43:683–691. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kagiava A and Theophilidis G: High
concentrations of dichloroacetate have minor effects on the
vitality of the mammalian nerve fibers: An ex-vivo
electrophysiological study. Anticancer Drugs. 22:273–276. 2011.
View Article : Google Scholar
|
|
33
|
Cao W, Yacoub S, Shiverick KT, Namiki K,
Sakai Y, Porvasnik S, Urbanek C and Rosser CJ: Dichloroacetate
(DCA) sensitizes both wild-type and over expressing Bcl-2 prostate
cancer cells in vitro to radiation. Prostate. 68:1223–1231. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Tong J, Xie G, He J, Li J, Pan F and Liang
H: Synergistic antitumor effect of dichloroacetate in combination
with 5-fluorouracil in colorectal cancer. J Biomed Biotechnol.
2011:7405642011. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Wang H, Wang L, Zhang Y, Wang J, Deng Y
and Lin D: Inhibition of glycolytic enzyme hexokinase II (HK2)
suppresses lung tumor growth. Cancer Cell Int. 16:92016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Ahn KJ, Hwang HS, Park JH, Bang SH, Kang
WJ, Yun M and Lee JD: Evaluation of the role of hexokinase type II
in cellular proliferation and apoptosis using human hepatocellular
carcinoma cell lines. J Nucl Med. 50:1525–1532. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Masoud GN and Li W: HIF-1α pathway: Role,
regulation and intervention for cancer therapy. Acta Pharm Sin B.
5:378–389. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Semenza GL: HIF-1: Upstream and downstream
of cancer metabolism. Curr Opin Genet Dev. 20:51–56. 2010.
View Article : Google Scholar :
|
|
39
|
Velpula KK, Bhasin A, Asuthkar S and Tsung
AJ: Combined targeting of PDK1 and EGFR triggers regression of
glioblastoma by reversing the Warburg effect. Cancer Res.
73:7277–7289. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Perez J, Hill BG, Benavides GA, Dranka BP
and Darley-Usmar VM: Role of cellular bioenergetics in smooth
muscle cell proliferation induced by platelet-derived growth
factor. Biochem J. 428:255–267. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Cerniglia GJ, Dey S, Gallagher-Colombo SM,
Daurio NA, Tuttle S, Busch TM, Lin A, Sun R, Esipova TV, Vinogradov
SA, et al: The PI3K/Akt pathway regulates oxygen metabolism via
pyruvate dehydrogenase (PDH)-E1α phosphorylation. Mol Cancer Ther.
14:1928–1938. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Yang X, Cheng Y, Li P, Tao J, Deng X,
Zhang X, Gu M, Lu Q and Yin C: A lentiviral sponge for miRNA-21
diminishes aerobic glycolysis in bladder cancer T24 cells via the
PTEN/PI3K/AKT/mTOR axis. Tumour Biol. 36:383–391. 2015. View Article : Google Scholar
|
|
43
|
Delaney LM, Ho N, Morrison J, Farias NR,
Mosser DD and Coomber BL: Dichloroacetate affects proliferation but
not survival of human colorectal cancer cells. Apoptosis. 20:63–74.
2015. View Article : Google Scholar
|
